Study of Spot Urine Protein Creatinine Ratio as an Index of Quantitative Proteinuria by Mohammed Niaz, A A
DISSERTATION ON 
STUDY OF SPOT URINE PROTEIN 
CREATININE RATIO AS AN INDEX OF 
QUANTITATIVE PROTEINURIA 
Dissertation submitted to 
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY 
In partial fulfilment of the regulations 
for the award of the degree of 
M.D. DEGREE IN GENERAL MEDICINE 
BRANCH – I 
 
THANJAVUR MEDICAL COLLEGE, 
THANJAVUR - 613 004 
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI - 600 032 
 
APRIL – 2013 
CERTIFICATE 
                  This is to certify that this dissertation entitled    
“ STUDY OF SPOT URINE PROTEIN CREATININE RATIO AS AN 
INDEX OF QUANTITATIVE PROTEINURIA”   is the bonafide original 
work of   Dr. MOHAMMED NIAZ .A.A  in partial fulfilment of the 
requirements for M.D. Branch – I (General Medicine) Examination of the 
Tamilnadu Dr.M.G.R. Medical University to be held in APRIL  - 2013. The 
period of the study was from April – 2012 to November -2012.  
 
 
Prof.Dr.S.MUTHUKUMARAN, M.D., 
               Unit Chief M-1 
       Dept. Of Internal Medicine, 
       Thanjavur Medical College, 
            Thanjavur – 613004. 
Prof.Dr.S.MUTHUKUMARAN,M.D., 
            Head Of the Department, 
           Dept. Of Internal Medicine, 
           Thanjavur Medical College, 
                 Thanjavur – 613004. 
 
 
 
 
 
Prof. Dr. C. GUNASEKARAN, M.D., D.C.H., 
DEAN in charge, 
Thanjavur Medical College, 
Thanjavur – 613 004. 
 
 Thanjavur Medical College 
THANJAVUR, TAMILNADU, INDIA-613004 
(Affiliated to the T.N Dr.MGR Medical University, Chennai) 
ETHICAL COMMITTEE 
CERTIFICATE 
Name of the Candidate :  Dr. MOHAMMED NIAZ .A.A  
Course   : M.D., GENERAL MEDICINE  
Period of Study  : April -2012 to November -2012  
College   : THANJAVUR MEDICAL COLLEGE  
Dissertation Topic  :  STUDY OF SPOT URINE PROTEIN CREATININE 
   RATIO AS AN INDEX OF QUANTITATIVE 
   PROTEINURIA                        
 The Ethical Committee, Thanjavur Medical College has decided to inform that 
your Dissertation Topic is accepted and you are permitted to proceed with the above 
study. 
 
Thanjavur         Secretary 
Date :           Ethical Committee 
 
 
 DECLARATION 
 
 
                    I, Dr. MOHAMMED NIAZ .A.A, solemnly declare that 
dissertation titled “ STUDY OF SPOT URINE PROTEIN CREATININE 
RATIO AS AN INDEX OF QUANTITATIVE PROTEINURIA ”  is a 
bonafide work done by me at Thanjavur Medical College, Thanjavur during 
April - 2012 to November - 2012 under the guidance and supervision of Prof. 
Dr. S. Muthukumaran, M.D., Unit Chief M-I, Department of Internal 
Medicine, Thanjavur Medical College, Thanjavur. 
                   This dissertation is submitted to Tamilnadu Dr. M.G.R 
Medical University towards partial fulfillment of requirement for the award of 
M.D. Degree (Branch - I) in General Medicine. 
 
 
 
Place: Thanjavur,     (Dr. MOHAMMED NIAZ .A.A) 
Date:  20-12-2012.             Postgraduate Student, 
                                                                      M.D. in General Medicine, 
        Thanjavur Medical College, 
           Thanjavur - 613 004. 
 
 
 
ACKNOWLEDGEMENT 
 
                          I gratefully acknowledge and express my sincere thanks to 
Prof.Dr.C.GUNASEKARAN, M.D.,D.C.H.,  Dean in charge, Thanjavur Medical 
College, Thanjavur for allowing me to do this dissertation and utilize the 
Institutional facilities. I am extremely grateful to Prof.Dr.S.Muthukumaran, 
M.D., Head of Department, Department of Internal Medicine, Thanjavur 
Medical College for his full-fledged support throughout my study and valuable 
suggestions and guidance during my study and my post graduate period. 
                   
                   I wish to express my deep sense of gratitude and respect to 
my beloved teacher and mentor  Prof.Dr.S.Muthukumaran, M.D., my 
Professor and Unit Chief, who is my guide in this study, for his timely 
suggestions, constant encouragement and scholarly guidance in my study and 
Post Graduate period. 
                
                I profoundly thank my respected professors Prof. Dr. P.G. 
Sankaranarayanan, M.D., Prof. Dr. K. Nagarajan, M.D., Prof. Dr. S. 
Manoharan, M.D., Prof. Dr. C. Ganesan, M.D., Prof. Dr. D. Nehru, M.D., 
D.M.R.D., and Dr. C. Paranthakan,  M.D., Registrar for their advice and 
valuable criticism which enabled me to do this work effectively. 
                     I would like to express my gratitude to Prof. Dr. T. 
Rajendran, M.D., DM (Nephro)., Associate Professor and Head, Department 
of  Nephrology for his immense help in the study which enabled me to complete 
this work. 
                           
                               My grateful thanks to Prof. Dr. N. SASIVATHANAM, 
M.D.,D.G.O.,  Head and Professor of Biochemistry, for her valuable guidance. 
I am grateful for the help rendered by the technicians of the Department of 
Biochemistry in the preparation of this study. 
 
                               My sincere thanks to Assistant Professors Dr. C. 
Paranthakan,  M.D., and Dr. V. Ravichandran,  M.D.,  for their motivation, 
encouragement and support. 
 
                        I am indebted to my parents, all my friends, colleagues, 
and my wife Raiza, for their constant encouragement throughout this study. 
                
                         Last but not least, I am grateful to all those patients who 
were the subjects for the study, without  whose co-operation this work would 
not have been possible. 
 
 
Your digital receipt
This receipt acknowledges that Turnitin received your paper. Below you will find the receipt information
regarding your submission.
Paper ID 291081168
Paper title STUDY OF SPOT URINE PROTEIN CREATININE RATIO AS AN INDEXOF QUANTITATIVE PROTEINURIA
Assignment
title Medical
Author Mohammed Niaz 20101177 M.D. General Medicine
E-mail getniaz4ever@yahoo.co.in
Submission
time 21-Dec-2012 10:56AM
Total words 8551
First 100 words of your submission
DISSERTATION ON STUDY OF SPOT URINE PROTEIN CREATININE RATIO AS AN INDEX OF
QUANTITATIVE PROTEINURIA Dissertation submitted to THE TAMILNADU DR. M.G.R. MEDICAL
UNIVERSITY In partial fulfilment of the regulations for the award of the degree of M.D. DEGREE IN
GENERAL MEDICINE BRANCH – I THANJAVUR MEDICAL COLLEGE, THANJAVUR - 613 004 THE
TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY CHENNAI - 600 032 APRIL – 2013 1
INTRODUCTION Increased protein in the urine is a common sign of kidney disease. A urine sample
can be easily obtained usually, and it can be analyzed by very simple techniques in the ward or in the
out-patient setup. Analysis of urine is one of the most rewarding tests in clinical...
Copyright 2012 Turnitin. All rights reserved.
 
STUDY OF SPOT URINE PROTEIN CREATININE RATIO AS AN 
INDEX OF QUANTITATIVE PROTEINURIA 
 
ABSTRACT 
 
 
 
 
 
Back Ground: 
 
                                    Quantitating protein in the urine has become more than 
just a diagnostic test. It can be even used for  prognostic purposes and to  
assess the effect of therapy. Commonly used method  to measure protein is 24 
hours urine collection,  which is  time consuming, cumbersome and often 
inaccurate. 
 
Aim : 
 Aim of the study was to compare spot urine protein- creatinine 
ratio with 24 hours urine protein as an index of quantitative proteinuria. 
 
 
Method: 
 
 68 patients with proteinuria with varying degrees of renal dysfunction 
were  included in this study. 24 hour urine protein estimation was done and 
protein creatinine ratio was calculated from a spot urine sample and compared. 
Study group was divided into 4 groups according to creatinine clearance and 
degree of proteinuria. Correlation between 24 hours urine protein and spot 
urine protein creatinine ratio, among the groups was statistically analyzed. 
 
 
Results: 
 
 
 
              There was  significant  correlation  between  24  hours  urine  protein  
and spot urine protein-Creatinine  ratio  (r  =  0.975) (  P  <  0.05). However  
least correlation was in patients with end stage renal disease having nephrotic 
range proteinuria ( r = 0.868) (P < 0.05). 
 
 
 
Conclusion : 
 
 
  Spot urine protein creatinine ratio is a useful index for quantification of 
proteinuria, which is easy to perform, inexpensive and less time consuming 
method. 
 
 
 
Key words: spot urine Protein-Creatinine ratio, 24 hour urine protein, 
Proteinuria, creatinine clearance 
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INTRODUCTION 
 
 
 
 
 
                      Increased protein in the urine is a common sign of kidney 
disease. A urine sample can be easily obtained usually, and it can be analyzed by 
very simple techniques in the ward or in the out-patient setup. Analysis of urine is 
one of the most rewarding tests in clinical medicine, as not only does it  uncover 
renal diseases but also frequently points to a specific diagnosis. Testing the urine 
for proteinuria has been part of the routine clinical examination for nearly 200 
years 
1
. 
 
                   Quantitating protein in the urine has become more than just a 
diagnostic test. Even a relatively small increase in the concentration of protein in 
the urine can be an early sign of renal disease and often precede a detectable 
change in glomerular filtration rate (GFR). 
                     
                     Protein in the urine is more than a simple marker of disease, as 
persistently high levels may cause further kidney damage and result in faster 
progression of the kidney disease. In addition, proteinuria is an independent and 
strong risk factor for cardiovascular disease and death, mostly in people with 
diabetes, hypertension and chronic kidney disease. Interventions that reduce the 
2 
 
amount of proteinuria also tend to retard the progression of kidney disease and 
improve the prognosis of cardiovascular disease. 
 
                       Proteinuria has become a common presentation of renal 
disease since sticks testing for protein became widely available, and there is 
frequent screening of apparently healthy individual.  Protein, blood or both can 
be found in the urine of apparently normal individual. Vigorous exercise, fever or 
UTI, and heart failure also can cause transient mild albuminuria. In such cases, 
tests should be done again when the trigger is no more present. There is still much 
controversy about who should have their urine tested and how anyone  found  to  
have  positive  test  should  be  further  investigated  and managed. The 
prevalence of proteinuria on a routine screening of healthy subjects has been 
found to be as high as 3.5%. It is important that all patients with proteinuria be 
carefully  evaluated to identify the cause of proteinuria. 
 
                     Normal daily protein excretion in an adult does not exceed 
150 mgs. Persistent proteinuria of > 1.0 gm/day, usually indicates renal 
disease.  Proteinuria  may  be  minimal  (<1.0  gm/day),  moderate  (1–3 gm/day) 
and heavy (>3 gm/day). Important causes of minimal proteinuria are chronic 
pyelonephritis, diabetic nephropathy, interstitial nephritis and chronic renal 
3 
 
failure. Moderate proteinuria is seen in nephritic syndrome and toxic 
nephropathies and heavy proteinuria indicates active glomerulonephritis. So 
quantification of protein is very important. 
 
                         Current methods for measuring proteinuria vary 
significantly. Commonly used methods are dipstick urine analysis, 24 hrs urine 
protein estimation  and  spot  urine  protein  Creatinine  ratio.   
 
                    Only very  few  Indian studies have compared the efficacy 
of 24 hours urine protein  with  spot urine protein creatinine ratio, which this study 
attempts to do. 
  
4 
 
 
AIMS AND OBJECTIVES 
 
1. To assess quantitative measurement of proteinuria by using spot urine 
protein creatinine ratio 
 
2. To compare spot urine protein creatinine ratio with 24 hours urine protein 
as an index of quantitative proteinuria. 
 
 
3. To determine the correlation of  spot urine protein creatinine ratio with 24 
hour urine protein at different levels of glomerular filtration rates (GFR). 
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REVIEW OF LITERATURE 
 
 
 
 
 
                  Proteinuria is a frequent finding in primary care practice.  
Hippocrates  was the first one to note  the  relation  between “Bubble  on  the  
surface  of  urine”  and  renal   disease 2400 years ago 6,   7. 
 
                Moderate amount of low  molecular weight proteins pass through 
the healthy glomerular basement membrane. Such proteins are normally reabsorbed 
by receptors on tubular cells. Normal individuals excrete <150 mg of total protein 
and <30 mg of albumin in urine every 24 hours. Other proteins found in the urine 
are either secreted by tubules (Tamm-Horsfall protein) or are small filtered proteins 
that have escaped reabsorption or degradation by renal tubule cells. Any level of 
protein excretion in the urine above 150 mg per 24 hours is abnormal and merits 
further evaluation.  
 
                 Under normal conditions, filtered proteins from plasma make half 
of this small amount of urinary protein and the rest is from the proteins which are 
secreted into the urine from urinary tract cells. These filtered proteins include small 
amounts of albumin (approximately 15% of the total urinary protein), 
immunoglobulins (5%), light chains (5%), β2 microglobulin (less than 0.3 %), and 
other plasma proteins (25%). The most prevalent tubular protein (and the most 
6 
 
abundant protein in normal urine) is Tamm-Horsfall protein. It is synthesised in the 
tubular cells of the ascending limb of the loop of Henle and is secreted into the 
urine. There is no noticeable sign of proteinuria unless the excretion is greater 
than several grams per 24 hours. In that case the urine may become frothy 
because proteins lowers the surface tension of the urine and permits relatively 
stable foam to form 
1
. This frothing may be a valuable way of  dating  the onset of 
profuse proteinuria. 
 
 
Protein handling by normal kidney 
 
 
                        The normal glomerular endothelial cells form a barrier and 
hold back cells and other particles. They are penetrated by large pores of 100nm 
called fenestrae  that  can  easily  be  traversed  by  proteins.  The  glomerular 
basement membrane traps most large proteins (>100Kda). The  urinary  side  of  
the  glomerular basement  membrane  is  covered by the foot process of 
epithelial  cells  (Podocytes). It produces  a  series  of  narrow  channels  (Slit 
diaphragm)  to  allow  passage  of  small  solutes  and  water.  This  slit diaphragm  
bridges the slits between the foot processes of the glomerular basement membrane  
8
. Negatively charged heparan sulfate proteoglycans cover the  visceral  epithelial  
cells
 6
. This negative charge and  size  selectivity  of  glomerular  basement  
7 
 
membrane  impedes  the passage  of  anion  molecules  such  as  albumin,   
globulin  and  large molecular  weight  protein  across  the  glomerular  wall.  
The  smaller proteins  that are filtered across the glomerular basement membrane 
are largely reabsorbed at the proximal  tubule and only small amount are 
excreted. 
 
8 
 
 
 
FIGURE 1 : FUNCTIONAL ANATOMY OF KIDNEY 
25
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A: Anatomical relations of kidney; B: Single nephron  ; C: Histology of normal glomerulus ; D: 
Cross section of glomerulus 
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FIGURE 2 : ELECTRON  MICROSCOPIC PICTURE OF NORMAL 
GLOMERULAR BASEMENT MEMBRANE 
 
. 
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FIGURE 3 : NORMAL PODOCYTE STRUCTURE 
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PATHOPHYSIOLOGICAL CLASSIFICATION OF 
 
 
PROTEINURIA 
 
 
 
A) BENIGN 
 
 
 1. Postural / Orthostatic proteinuria 
 
 
 2. Functional 
 
 
 3. Transient idiopathic 
 
 
 4. Intermittent 
 
 
 
B) PATHOLOGICAL 
 
 
 1. Glomerular 
 
 
 2. Tubular 
 
 
 3. Overflow 
 
 
 4. Secretory 
 
 
 
 
 
A) BENIGN PROTEINURIA 
 
 
                 This is a transient proteinuria that occurs with normal renal 
function, bland urinary sediment, normal blood pressure and without any 
significant edema. 24 hour urine protein is usually less than 1 gm.  They do not 
indicate any significant renal disease and disappears on repeated testing. 
 
 
 
12 
 
1) POSTURAL / ORTHOSTATIC PROTEINURIA 
 
 
 
 Benign orthostatic proteinuria is mostly seen in tall and young 
individuals, and occurs when the patient is in the lordotic position. It is diagnosed 
by split urine protein excretion examination. Urine specimen collected during the 
day time shows raised amount of protein, but not in the overnight sample collected 
immediately on waking up. Urine sediment does not show any abnormality, and 
proteinuria will be less than 1 gram/day. In most of the patients, proteinuria will 
disappear within ten years; however, in a small portion, overt renal disease may 
develop later. 
 
Springberg et  al  
11    
found that  long  term  prognosis  of 
 
 
orthostatic proteinuria is benign in virtually all cases over many decades.  Data 
on renal biops ies  on orthostat ic  proteinuria are confusing.  Some showed 
minor glomerular changes 
12
. Posture affects urinary prote in excre t ion, 
probably via an inc reas e  in  glomerular capillary hydrostatic pressure and 
change in permeability of the glomerular capillary walls
13
. An a l t e r na te  
explanation is entrapment of renal veins 
14 15
. 
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2) FUNCTIONAL 
 
 
               It is  a  benign  proteinuria  due  to  changes  in  glomerular  ultra 
filtration pressure and /  or membrane permeability. It is seen in Fever, Exercise, 
Cardiac failure, Emotional stress and acute illness. It is usually less than 0.5 
gm/day but may be as heavy as 5.0 gm/day (following marathon running). It 
disappears with the resolution of causative disorder 16. 
 
              Kallmeyer et al 
17  
found that recent exercise can induce several 
gram of protein per  liter of urine, sometimes together with haematuria and even 
casts. So called jogger’s nephritis. Post exercise proteinuria is about 15 to 20 
times the resting range of proteinuria and require about 4 hours to regain resting 
value in the recovery period 
18
. Poortmans et al 
19 
found that proteinuria was 
influenced mostly by the intensity of exercise rather than its duration. 
 
 
 
3) IDIOPATHIC PROTEINURIA 
 
 
           This is  seen  in  young  healthy  adults.  This  dipstick  positive 
proteinuria disappears spontaneously by next clinical visit. 
 
4) INTERMITTANT PROTEINURIA 
                              This benign proteinuria is found in half of their different 
urine samples in absence of other renal or systemic abnormalities. 
14 
 
B) PATHOLOGICAL PROTEINURIA 
 
 
               This is persistent proteinuria that is detected on multiple 
ambulatory clinical visits. This is seen in both recumbent and upright position 
and usually signals a structural renal disease. 
 
 
 
1) GLOMERULAR PROTEINURIA 
 
 
                  Glomerular proteinuria takes place when injury to the glomerulus 
lead to an ultra filtrate which constitutes partial rise in the clearance of serum 
proteins. This type of proteinuria is peculiarized by an excessive amount of 
albumin in urine 
20
. Due to preservation of selectivity and large  concentration of 
albumin in blood, glomerular  proteinuria is  85  to  90  %  albumin, accompanied  
by  pre- albumin, orosomucoid, transferrin and relatively low molecular weight 
proteins. They are readily detected by stick or turbidimetric methods. Glomerular 
proteinuria is often classified either as non nephrotic (< 3.5 grams/ day/1.73 m
2 
BSA) or nephrotic (>3.5 grams/day/1.73 m
2 
BSA). McConnell et al on evaluation 
of proteinuria found that urinary excretion of > 2 gm / day is usually a result of  
glomerular disease 
21
. In glomerular  proteinuria, there is increased glomerular 
capillary permeability to high molecular weight anionic plasma proteins. How the 
glomerular barrier is damaged so that it leaks more than normal remains unclear 
22
. This may be due to : 
15 
 
  - Loss of fixed anionic charge (congenital nephrotic syndrome, 
minimal change nephropathy) 
 -  Detachment of epithelial podocytes from basement membrane 
23.
 
 
 
 -  Immune aggregates 
 
 
 -  Increase in glomerular capillary pressure. 
 
 
 
                              
                           The filtered proteins, that reach the tubules overwhelm the 
limited capacity of tubular  reabsorption and cause these proteins to appear in 
urine. 
            Glomerular disease is classified as primary when the pathology is 
confined to the kidney and secondary when it is a part of multi system disorder.  
Glomerular proteinuria is of two types: 
 Selective Proteinuria 
 
 
 Nonselective Proteinuria 
 
 
 
                    In selective proteinuria the clearance ratio of immunoglobulin 
to albumin or transferrin is less than .10 (<10%). In nonselective proteinuria the 
clearance ratio of immunoglobulin to albumin or transferrin is more than 0.50 
(>50%). 
 
 
 
 
16 
 
GLOMERULAR PROTEINURIA - CAUSES : 
 
 Primary glomerular disorders 
Minimal change, FSGS,  membranoproliferative, mesangial 
proliferative, membranous, crescentic 
 Hereditary 
Alport’s syndrome, nail – patella syndrome , Fabry’s disease 
 Infectious 
Bacterial, fungal, protozoal, viral,  and helminthic causes, including 
bacterial endocarditis, hepatitis B and C, visceral abscesses, PSGN, 
secondary syphilis, malaria , HIV 
 Metabolic 
DM 
 Immunologic 
SLE, MCTD, Sjogren’s syndrome, HSP, Wegener granulomatosis, 
microscopic PAN, Goodpasture’s syndrome, cryoglobulinemia 
 Medications 
lithium, NSAIDs, Penicillamine, ACE inhibitors,  heroin, gold or 
mercury containing compounds 
 Neoplasms 
17 
 
lymphoma , Multiple myeloma, leukemia, 
 colon, lung, or breast carcinoma 
 Miscellaneous 
congenital nephrotic syndrome , Sickle cell disease, reflux 
nephropathy, cirrhosis, immunotactoid glomerulopathy, 
amyloidosis, allergies, immunizations 
 
 
 
 
2) TUBULAR PROTEINURIA 
 
 
 
                 Proteinuria results from the damage of proximal tubule 
so that normally reabsorbed protein, principally of low molecular weight, pass 
into the urine .This usually occurs as a part of the Fanconi syndrome of 
proximal tubular  dysfunction. Tubular proteinuria usually does not exceed 
2gm per day 
24 25
.  
  
  Tubular proteinuria is originated from 3 sources : 
1. Damaged tubules incompletely reabsorb low molecular weight proteins filtered by the 
glomerulus, like β2 microglobulin &  amylase. 
2.  Damaged tubules secrete cellular enzymes & brush border components , like N-
acetylglucosaamine &  lysozyme, into the urine. 
18 
 
3.  The tubular cells of the acending limb of the loop of Henle & the distal nephron may 
secrete Tamm-Horsfall proteins in excess amount when tubulointerstitial damage occurs. 
 
                               Beta 2-Microglobulin is one of the many micro globulin 
which make up tubular proteinuria. Normal level of Beta 2- Microglobulin in 
urine is less than 0.4 mcg/L. It can be assessed by RIA or ELISA. The urinary 
albumin - β2 microglobulin ratio of 10:1 indicates tubular proteinuria. In 
glomerular proteinuria, this ratio will be more than 1,000:1 
3
. In normal 
conditions,  albumin - β2 microglobulin ratio ranges between 50:1 and 200;1. Further 
measurement of Beta 2-M Lysozyme may help in distinguishing type of 
urinary tract infection besides diagnosis of heavy metal poisoning 
26 27
. Urinary 
protein electrophoresis, Immuno electrophoresis, and immunofixation also may 
aid in distinguishing tubular and glomerular proteinuria. 
 
 
 
TUBULAR PROTEINURIA – CAUSES 
28
 
 
 
 
-Hypertensive nephrosclerosis 
 
 
-Tubulo interstitial diseases due to 
 
 
-Fanconi syndrome 
 
 
-Heavy metals 
 
 
-Uric acid nephropathy 
 
19 
 
 
-Acute hypersensitivity 
 
 
-Interstitial nephritis 
 
 
-Sickle cell disease 
 
 
-Drugs (NSAID, Antibiotics) 
 
 
 
 
 
3) OVERFLOW PROTEINURIA 
 
 
 
                         When a low molecular weight protein is produced in 
abnormally excessive amount in the body, it will be filtered through the normal 
glomerulus and the normal tubules may fail to reabsorb it completely, as it 
exceeds its normal capacity to reabsorb. This is known as overflow proteinuria.  
This happens in monoclonal gammopathies like multiple myeloma, in 
intravascular hemolysis (hemoglobinuria), & in rhabdomyolysis 
(myoglobinuria). It  may be recognized by the presence of aberrant spike i n 
urinary  electrophoresis. 
28 29
 
 
 
 
OVERFLOW PROTEINURIA –CAUSES 
 
 
-  Multiple myeloma 
-  Hemoglobinuria 
-  Myoglobinuria 
20 
 
-  Rhabdomyolysis 
-  Lymphoproliferative disorders 
 
4) SECRETORY PROTEINURIA 
 
 
 
                It occurs due to secretion of proteins into the urine after 
glomerular filtration.  About  20  to   30  mg/24  hours  of  non  plasma  protein  
is contributed by renal tubules and lower urinary tract.  Mostly they are 
formed by Tamm-Horsfall proteins
29. 
Some secretary IgA is added by lower  
urinary  tract  including the  urethral  glands  together with  trace quantity of 
protein of prostatic or seminal vesicular organ 
30 31
. 
 
             Tamm-Horsfall protein is secreted by the ascending thick limb and 
early distal  convoluted  tubule  into  the  tubular  fluid.  It  is  an  easily 
polymerized glycoprotein . They form the  major constituent of renal tubular 
casts 
32
, along with albumin and traces of many plasma proteins, including 
immunoglobulins 
33
. In Myeloma, casts  contain paraproteins polymerized with 
Tamm-Horsfall protein, and may show a micro fibrillar structure that will stain 
positive with congo red, even though no amyloid is present in renal tissue. 
 
 
 
 
 
21 
 
Table 1: DEGREE OF PROTEINURIA AND CAUSES 
20
 
 
 
 
 
 
Daily protein excretion Causes 
0.15 – 2.0 gm 
Mild glomerulopathies 
 
 
Tubular proteinuria 
 
 
Overflow proteinuria 
2.0 –3.5 gm Usually Glomerular 
>3.5 gm Always glomerular 
 
 
 
 
 
 
 
MICROALBUMINURIA 
 
 
                                                             It denotes urinary albumin excretion of 30 to 300 mg 
per day or  30 to  300  mg/gram  creatinine  in  a  spot  collection 
34
.  Conditions 
like  essential  hypertension and diabetes may manifest as microalbuminuria. It is 
established that those with microalbuminuria have increased risk of developing 
overt diabetic nephropathy, renal failure and cardiovascular complications in 
future. The exact mechanism of micro albuminuria is not understood well. The 
explanation to the question why it is associated with these conditions is yet to be 
established. It may be the earliest c lin ica l  manifes ta t ions  o f  
22 
 
invo lvement  of k idney in diabetes  me l l itus .  
 
                     Microa lbuminur ia  is the most reliable indicator of 
incipient diabetic nephropathy within the first 10 years of type 1 diabetes, when the 
majority of patients with microalbuminuria will progress to overt nephropathy within a 
further 10 years. It is a less reliable predictor of nephropathy in older patients with type 
2 diabetes. The prevalence of microalbuminuria rises to reach 50 - 60%  after  20-
30  years  duration  of  diabetes  
35.  Standard dipsticks for protein fail to detect 
microalbuminuria. It can be measured only by sensitive methods. It can be tested 
by immunometric dipstick micral test. Screening is conducted yearly in patients 
with type 2 diabetes, but can be deferred for the first 5 years in those with type 1 
diabetes
38
. 
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METHODS OF DETECTING AND MEASURING PROTEINURIA 
 
 
 
A) DETECTION OF PROTEINURIA 
 
 
1 Dipstick analysis 
 
 
2 Precipitation methods 
 
 
B) QUANTIFICATION OF PROTEINURIA 
 
 
1. Turbidimetric method 
 
 
 - Sulphosalycilic acid 
 
 
 - Benzethonium chloride 
 
 
 - Trichloroacetic acid 
 
 
2. Biuret method 
 
 
 - Copper reagent 
 
 
 - Tsuchiya reagent 
 
 
 - Fowlin-Lowry 
 
 
3. Dye binding technique 
 
 
 - Pyrogallol red 
 
 
 - Coomassie brilliant blue 
 
 
 - Ponceau S 
 
 
 4. Radio immune assay 
 
 
 5. Enzyme linked immunosorbent assay 
 
 
 
24 
 
 C)  CHARECTERIZATION OF PROTEINURIA 
 
 
 1. Immune electrophoresis 
 
 
 2. Column gel chromatography 
 
 
 3. Agarose gel electrophoresis 
 
 
 4. Polyacrylamide gel electrophoresis 
 
 
 5. Isoelectric Focussing 
 
 
 
 
 
 
A ) DETECTION OF PROTEINURIA 
 
 
 
1) DIPSTICK ANALYSIS 
 
 
               It is one of the most commonly used method to detect proteinuria 
in out patient settings.  It semi quantitatively measures  the urine protein 
concentration. Tetrabromophenol is buffered to a pH of 3, and with rising protein 
concentration, a yellow – to – green colour change can be observed . 
 
          It preferentially detect negatively charged urinar proteins (albumin). 
The lower threshold concentration for detection of protein by the routine dipstick is 
around 15 to 20 mg/dl which is roughly equivalent to a 24 hour urine protein of  
300 to 500 mg 
2
. Light chains and some low molecular weight protein are not 
detected by stick tests.  The sticks are buffered to keep the pH constant. Leaving 
25 
 
the sticks in the urine will wash out the buffer and give a false reading. They 
should be read immediately.  
 
Ralston et al 
39  
found that dipstick testing though nearly 100% 
 
 
sensitive, has  a  poor  specificity  due  to  high  false  positive  rates. Specificity 
being 40%  with 1 + , 83% with 2 + and 48% with 3 + readings. 
 
Scale for detecting proteinuria on routine urine dipstick: 
         Negative = < 15 mg/dl 
         Trace = 15 to 30 mg/dl 
         + = 30 to 100 mg/dl 
         ++ = 100 to 300 mg/dl 
         ++ + = 300 to 1000 mg/dl 
         ++++ = more than 1gram/dl 
 
                                 David son et al 
40 
while evaluating the relation 
between dipstick positive proteinuria and albumin-creatinine ratio found that 
dipstick positive proteinuria of ≥  1 + may be used as a substitute for albumin -
Creatinine ratio in random  urine  specimen for proteinuria quantification. 
Presently, the American diabetic association and the Kidney foundation do no t  
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consider dipstick urine test for  protein for evaluation of  diabetic nephropathy.  
Meyer et al 
42  
found out that sixty six percentage of patients with negative or  
trace protein had significant proteinuria when the specimen was compared with 
24 hours urine collection. 
 
 
 
FALSE POSITIVE DIPSTICK PROTEINURIA 
 
 
 - Ph > 7 
 - Pus  
 - Highly concentrated urine 
 
-     semen 
 
 
 - Gross Haematuria 
 
 
 - Dipstick immersed too long 
 
 
 - Drugs like  Penicillin, Sulfonamide or Tolbutamide. 
  
-     Radiocontrast 
 
 
 - vaginal secretions 
 
 
 
 
FALSE NEGATIVE DIPSTICK PROTEINURIA 
 
 
 - Highly dilute urine  
 
 
  - non albumin proteins such as immunoglobulins  
  - low molecular weight proteins 
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PRECIPITATION METHOD 
 
 
 
Kjeldahl :- 
 
 
This precipitation method measures protein by measurement of 
precipitated Nitrogen. Detection limit is 10-20 ng/l. 
The heat test, eventhough it is valid, is not usually done nowadays. A 
sulphosalycilic acid precipitation test can be used instead. 
 
 
QUANTIFICATION OF PROTEINURIA 
 
 
 
 
 
1) Turbidimetric method: 
 
      In this, addition of Trichloro acetic acid or sulphosalicylic acid 
alters colloid properties and produces  turbidity  to  be  read  in  densitometer. 
Occasionally Benzethonium is also used instead of sulphosalycilic acid.  Its 
detection limit is 50-100 mg/l.  The disadvantage of this method is that it is 
imprecise and gives different readings for albumin and globulin.  The advantage 
of this  test is that it can be easily performed and it has a  greater sensitivity 
for proteins like Bence Jones. A positive sulphosalycilic acid test result with a 
normal dipstick denotes the presence of non albumin proteins in the urine as might 
28 
 
occur with multiple myeloma. A few ml of freshly voided, centrifuged urine  
specimen is added with equal amount of three percentage sulphosalycilic acid. 
Turbidity will d e v e l o p  w i t h  a  protein concentration of more than or equal to 
4 mg/dl. False positive results may occur i f patient had recent administration  of  
radio contrasts or he/she is on drugs like Penicillin or  sulfonamides  
43
.  Ahighly 
buffered alkaline or dilute urine sample may give a false negative report. 
 
 
2) Biuret Method:- 
 
 
              
              This requires precipitation of protein, by using a copper or 
Tsuchiya reagents. Its detection limit is 50 mg/l. They are used in some 
laboratories to measure 24 hours urine protein. 
 
 
 
 
3) Dye binding technique:- 
 
 
 
                This is most widely used technique for quantification of urinary 
proteins.  It is based on the interaction between protein and  a  dye.  They  are  
reliable,  accurate  and  an  easy  way  for assessing proteinuria.  Commonly used 
dyes are pyrogallol red, Coomassie brilliant blue and Ponceau S. 
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                   Pyrogallol red dye is the most commonly used dye for dye 
binding technique.  They over come many of the traditional limitations  associated  
with  colorimetric  proteins, as  there  is minimal staining of plastics and 
glassware. This  makes it an ideal dye for most chemical analyzers.  Pyrogallol red 
combines with sodium molybdate to form a red complex.  Proteins, in an acidic  
medium  combine  with  this  red  complex  and  form  a bluish purple colored 
complex. The intensity of the  color formed is directly proportional to amount of 
proteins present. 
 
Proteins + Pyrogallol red + Molybdate 
 
 
In acidic medium 
 
 
Bluish purple colored complex. 
 
 
 
 
 
 
COLLECTION OF URINE 
 
 
There are  various  methods  for  collection  of  urine. Currently acceptable 
methods are :
44
 
1) 1-2 hour collection 
 
 
2) Over night (8-12 hour) collection 
 
 
3) 24 hour collection 
 
4)  Random urine sample for protein Creatinine ratio 
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                              A 24 hours urine collection is usually required for a 
precise quantitative and qualitative analysis of  the amount and composition of 
urinary proteins. The urine is collected by emptying the bladder and discarding the 
first urine on the morning of collection, and meticulously collecting all ensuing 
urine for the next 24 hours. The final urine at the end of the 24 hour period is also 
collected.  
                         The timed specimen (24 hour or over night) is more 
sensitive but the Protein- Creatinine  ratio is more practical and convenient for 
the patient 
44
.  
 
 
 
STORAGE OF SPECIMEN: 
 
 
         
                            Estimation of  protein  from  urine  should  be  done  as  
soon  as possible after the  collection. If estimation of protein is delayed by 24 
hours  then  it  should  be  stored at  a  temperature  less  than  18  degree 
centigrade. Urine can  be stored at  this temperature  for a  maximum period of 3 
days. No preservative is usually required if the urine is refrigerated during the 24 
hour period. A preservative like acetic acid  may be added to the collection vessel 
if refrigeration is unaccessible. Refrigerated urine sample should be allowed to 
reach at least 10 degree centigrade before analysis. It is observed that freezing 
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samples decrease  albumin, but mixing immediately before assay eliminates this 
effect. 
 
 
 
ADEQUACY OF COLLECTION 
 
 
 
            Creatinine is produced from skeletal muscle Creatine, as a 
metabolic product, at  a constant  rate. The  amount of creatinine produced is 
directly  proportional  to skeletal muscle mass. With an unfluctuating state of renal 
function, each gram of creatinine in 24hour urine collection equate 18.5gms of 
fat free skeletal muscle mass
45. 
 
                      As the concentration of creatinine remains relatively constant 
on a daily basis it can be used to assess the adequacy of timed urine collections. 
The urinary creatinine excretion is measured and compared with normal expected 
ranges of creatinine excreted per day.   The normal creatinine excretion per day is 
as follows: 
Males : 18 – 25 mg/kg/day 
 
Female : 15-20 mg/kg/day 
 
 
 
If expected Creatinine is similar to what has been measured in previous timed 
urine sample, the collection is likely to be accurate. 
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URINE PROTEIN CREATININE RATIO 
 
 
 
 
 
                       The quantification of proteinuria is commonly used in the 
diagnosis,  assessment and  prognosis of glomerular   disease 
46
. 
              Quantitative estimation of daily urinary protein excretion is usually 
done by 24 hours urine collections.  However such timed collections of urine are 
inconven ient , cumbersome and a t  times unre l iab le  because  of frequent 
errors in collection and up to a third of the specimens have to be rejected 
47
. 
          
                       A urinary protein – creatinine concentration ratio on spot urine 
sample can be used as a quick assessment of proteinuria, and it can be useful as an 
alternative for repeated full 24 hour urine collections to assess responsiveness to 
therapy 
48  49  
. 
 
 The amount of dilution of the urine will directly affect protein 
concentration. The concentration of  creatinine in the urine serves as an internal 
control for the urine dilution. The ratio of protein to creatinine is independent of 
urine concentration, as concentration affects both parameters equally. There is 
evidence that untimed or spot urine specimen is adequate for quantification of 
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proteinuria. Since the rate of creatinine excretion remains fairly constant, the ratio 
of protein to creatinine on a random specimen is a good estimate of amount of 
protein excreted. It is important to note the units in which the laboratory reports 
protein and creatinine, as equivalent units should be used to generate a valid ratio. 
 
                 The  protein and creatinine concentration in urine are measured by 
routine biochemical analyzers and the  ratio is determined. Assuming that the 
average individual excretes approximately 1 g of creatinine per day, normal spot 
urine protein – creatinine ratios on random samples usually fall below 0.2 (mg 
protein per mg creatinine), whereas values greater than 3 suggests the presence of 
nephrotic range proteinuria. For instance, a ratio of 2 roughly translates to a 24 
hour urine protein excretion of 2g. The preciseness of the ratio is diminished when 
creatinine excretion is either markedly increased in a muscular man (the ratio will 
underestimate proteinuria) or markedly reduced in cachectic patient (the ratio will 
overestimate proteinuria). 
 
                        Gisberg et al 
48
, on quantitative estimation of proteinuria 
from an single void urine, found an excellent correlation between the Protein–
creatinine ratio in a single urine sample and the  protein content of a 24 hour urine 
collection. Correlation between 24 hours  urine protein   excretion and the urinary 
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Protein – Creatinine ratio  has  been  validated  in  several  diseases, including 
preeclampsia, diabetes mellitus,  and rheumatic disease 
39 46 50
. 
 
                      Silink et al 
51 
studied the relationship between albumin  
concentration in 24 hour ur ine  and  ur ine  sa mple s  at various times of the 
day, in patients with type 1 diabetes mellitus. He found out that the correlation 
was highest with first  morning urine sample. Hence the urine collected from the 
first morning sample for Protein- Creatinine ratio, is an acceptable alternative to a 
24 hours urine collection for proteinuria quantification in clinical follow up and 
screening 
52 53
. 
 
                   Rodby et al 
46  
in is study found that time of day when the 
random urine specimen was obtained did not impact on the ability to predict 24 
hours urine protein from random urine specimen. 
 
 
                 Another method  for  quantification  of  proteinuria  in  spot  urine 
sample is by measuring urine Protein – Osmolality ratio. Wilson et al  54 found that 
urinary protein osmolality ratio indicated quantitative proteinuria with  reasonable  
predication  and  is  more useful  than  qualitative urine analysis for  detecting or 
assessing  proteinuria. 
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Zelmanovitz et al 
55  
found  that proteinuria estimation  in a 
 
 
random urine sample is a simple and reliable method for screening and diagnosis of 
overt diabetic nephropathy. 
 
                             Ruggenenti et al 
56 
, on study of 24  hours  urine  protein  
excretion, spot morning urine Protein-Creatinine ratio and  glomerular filtration  
in  chronic renal  disease in patients without diabetes, found Urine Protein -  
Creatinine ratio more accurate  than 24 hours urine protein measurement. 
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FIGURE 4 : APPROACH TO PATIENTS WITH PROTEINURIA 
25
 
 
 
 
 
Proteinuria on repeated urine 
dipsticks 
Quantify proteinuria 
Substantial (> 1 g/day) Low grade (< 1 g/day) 
Are there features of significant renal disease ? 
eg. Hematuria 
Hypertension 
Abnormal renal function 
family history of renal disease 
history suggestive of systemic disorder 
 
Yes 
consider renal biopsy 
No 
Observation 
Urine test, BP, creatinine every 6 - 24 months 
Re - refer if anything changes 
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TABLE 2 : FURTHER INVESTIGATIONS IN PROTEINURIA  
28 
 
 
 
Sl.No Investigation Inference 
1   ANA 
  in SLE and other connective tissue  
  diseases 
2   ASO titer 
  Raised in post streptococcal 
 
  Glomerulo nephritis 
3   C3, C4   decreased in glomerulonephritis 
4   ESR 
  Normal value helpful in ruling out  
 
  inflammatory and  infectious causes 
5   FBS & HbA1c   Elevated in diabetes mellitus 
6   Hb, PCV   Low in CKD 
38 
 
7 
  HIV, VDRL and 
 
 
  Hepatitis serology 
  Human immunodeficiency virus,  Syphilis,  
  Hepatitis B & C  can lead to glomerular 
  proteinuria 
8   Serum Electrolytes  
  Helpful in diagnosing etiology and 
  complications 
9   Lipid profile    Increased in nephrotic syndrome 
10   Serum albumin    decreased in nephrotic syndrome 
11 
  Chest Radiograph  
 
  may provide evidence of systemic 
 
 
  disease (e.g., sarcoidosis) 
12   Serum urate 
  Urinary tract calculi, 
 
  tubulointerstitial disease 
13   Renal USG   To rule out structural renal disease 
14 
  Serum and urine 
 
 
  protein electrophoresis 
  Abnormal pattern in multiple myeloma 
 
 
 
 
 
 
 
 
39 
 
INVESTIGATIONS DEPENDING ON TYPE OF PROTEINURIA 
 
 
Glomerular proteinuria: 
 
 
- Serum immunoelectrophoresis 
 
 
- Urine immunoelectrophoresis 
 
 
          - Complements C3, C4, 
 
 
          - Renal biopsy 
 
 
          - ANA 
 
 
          - VDRL 
 
 
          - HIV/HBV/HCV serology 
 
 
 
Tubular proteinuria: 
 
 
          - B2 Miroglobulin/Albumin excretion ratio 
 
 
          - Urinary electrophoresis 
 
 
           - Heavy metal screening 
 
 
Over flow Proteinuria: 
 
 
           - Serum / urine electrophoresis 
 
 
           - Urinary light chains 
 
 
           - Urinary spectrophotometry 
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TABLE 3 : INTERPRETATION OF FINDINGS OF MICROSCOPIC 
 
EXAMINATION OF URINE 
57 
 
 
 
 
No: Microscopic finding Pathological process 
1 
 
  Fatty casts, free fat or oval 
 
  fat bodies 
  Nephrotic syndrome 
2 
  Leukocytes, Leukocyte casts  
  with bacteria 
  Urinary tract infection 
3 
  Leukocytes, Leukocyte 
 
  casts without bacteria 
  Renal interstitial disease 
4   Normal shaped erythrocytes   Lower urinary tract lesion 
5   Dysmorphic erythrocytes   Upper urinary tract lesion 
6   Erythrocytes casts   Glomerular disease 
7 
  Waxy, granular  or  cellular 
 
  casts 
  Advanced chronic renal disease 
8   Eosinophiluria 
  drug  induced  acute interstitial 
  nephritis 
9   Hyaline Casts 
  Not associated with proteinuria; 
  Various physiologic states, such as 
  strenuous exercise or dehydration 
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URINE MICROSCOPY 
 
 
 
                                         A B 
 
 
 
 
 
 
 
 
Phase contrast image of red blood cells showing : 
 
 
A- Glomerular  bleeding  with  many  dysmorphic  forms  including 
acanthocytes (Teardrop forms) 
B- Bleeding from lower in the urinary tract 
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                                       C                   D 
 
 
 
 
 
 
 
 
 
 
 
Phase contrast images showing: 
 
 
C-Hyalin casts (Normal feature of urine). 
 
 
D-Numerous  red  cells  and  a  large  red  cell  cast  in  acute  glomerular 
inflammation. 
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E 
 
 
E : Fatty cast & Oval fat body 
 
 
 
 
 
F 
 
 
F : Waxy cast 
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                                  G                                   H        
  
 
 
                       G : Leukocyte cast H : Eosinophiluria 
 
 
 
I 
 
 
I : Granular cast
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INFLUENCE   OF   REDUCING   PROTEINURIA   ON   RENAL 
 
 
OUTCOME 
 
 
 
 
 
             Proteinuria is an independent risk factor for progression of renal 
disease.  A number of smaller studies in non diabetic patients suggested that 
the magnitude of reduction in urinary protein excretion independently  predicted  
the  magnitude  in  the  preservation  of  renal function  
58
. However  it  was  
not  until  the  past  decade  that  larger prospective trails provided support for 
this observation. 
 
 
 
                In APRI trial, in which patients were treated with Benazapril, 
the greatest reduction in risk  for the development of a renal end-point was seen 
in patients with the greatest degree of proteinuria 
59
. 
 
 
 
              In MDRD study, reduction in blood pressure to levels of 
approximately 125/75 mm Hg in conjunction with a low-protein diet in 
patients  with  greater   degrees  of  proteinuria  (>1gm/24  hours)  was 
associated with a slow rate of loss of GFR 
60
. 
 
                REIN trial demonstrated that ramipril reduced the relative risk 
of developing end stage renal failure by five fold and decreased the risk of 
massive proteinuria 
61
. 
46 
 
 
 
 
              In another study with ACE inhibitors they found that benefit of 
therapy with ACE  inhibitors was time dependent, with greater benefits being 
observed in patients treated for longer  periods 
62
.Thus the above studies clearly 
shows that drugs and dietary intervention will be needed to reduce the risk of 
proteinuria. 
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MATERIALS AND METHODS 
 
 
 
 
Setting     :  In-patients, Department of Medicine 
and Nephrology 
     Thanjavur Medical College Hospital, 
     Thanjavur. 
 
 
Ethical committee Approval :  obtained. 
 
 
Design of study    :  Single center, prospective observational 
study. 
 
 
Period of study    : April -2012 to November -2012 
 
 
Sample size    :  68  patients. 
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SELECTION OF STUDY SUBJECTS 
 
INCLUSION CRITERIA: 
1. Patient of either sex 
2. Patient of age 13 or above 
3. Nephrotic syndrome 
4. Diabetic nephropathy 
5. Systemic lupus erythematosus / Mixed connective tissue disease 
6. Chronic kidney disease 
 
EXCLUSION CRITERIA: 
1. Patients of age less than 13 years 
2. Gross hematuria 
3. Females during their menstruation period 
4. Patients with febrile illness 
5. Dehydration 
6. Intense activity 
7. Cardiac failure 
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METHODOLOGY 
 
              A Study of 68 patients satisfying the inclusion and exclusion 
criteria managed  by  Medicine  and  Nephrology  departments  of  
Thanjavur Medical college were recruited for this study. The study was 
undertaken for eight months, from April 2012 to November 2012. 
 
               The baseline data of patients including age, sex and 
bodyweight were acquired. Informed consent was taken from all the 
participants. A detail  history  of  the  illness,  general  physical  
examination  and systemic examination was  done. Clinical presentation, 
medical illness, physical   examination  finding,  baseline  laboratory  
investigations,  24 hours urine protein excretion, 24 hours urine creatinine 
and spot urine sample protein – Creatinine ratio were estimated and were 
noted down in the proforma. 
 
 
 
 
       For the estimation of 24 hours urine proteins, these patients 
were provided with plastic can (5 liters capacity) w ith p reservat ive  
(ace t ic  ac id )  to collect their 24 hours urine.  The time was noted and 
patient  was advised to collect  their  entire  24 hours  urine (excluding the 
first morning urine sample on the first day) in the  can provided to them, 
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including the last void urine at the end of 24 hours. These patients were also 
advised to collect an untimed urine sample on the next day after the 24 
hours urine collection. Patients were advised to avoid intense physical 
activity. No specific advice was given about water intake or dietary protein 
intake. 
 
                The urine for 24 hours protein and spot protein 
concentration was estimated by using dye binding technique with 
Pyrogallol red in auto analyzer (BTS – 350). 
 
 
 
            24 hours urine creatinine and Spot Urine Creatinine was 
estimated by using modified Jaffe’s method in auto analyzer (BTS – 
350). 
 
        All analyses were performed with strict adherence to standard 
operating procedures. 
       Expected minimum creatinine excretion per day was predicted 
as 18 mg/kg/day for males and 15 mg/kg/day for females. The adequacy 
of 24 hour urine collection was assessed by comparing the 24 hour 
urine creatinine with the expected creatinine. If the expected creatinine 
is similar to to what has been measured in 24 hour urine sample, the 
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collection was taken as adequate. Sample with incomplete collection 
was discarded and the participant was advised to recollect in a proper 
way. 
           
       Spot Urine Protein – Creatinine ratio was calculated by dividing 
the spot urine protein concentration by the spot urine creatinine 
concentration (both expressed in mg/dl). 
 
 
                          
                     
                        
 
 
 
 
                             Urine samples were evaluated by sulphosalicylic acid  
test for albumin, Benedict’s test for sugar and by microscopy for deposits. 
Serum biochemical analysis was done using auto analyzer (BTS – 350) and 
complete blood count by using SYSMEX KX – 21 cell counter.  
 
                   Patients were divided into 2 groups depending on 
Creatinine clearance. Creatinine clearance was estimated from age, sex, 
weight and serum Creatinine of the individual by the COCKCROFT – 
GAULT 
63
 formula given below : 
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Creatinine [140-Age (yrs)] X Wt (kg) 
Clearance (male)  = 
serum creatinine X 72 
 
 
 
 
Creatinine clearance =  [140-Age (yrs)] X Wt (kg) X 0.85  
      (female) 
   serum creatinine  X 72 
 
 
 
 
 
 
Group I: 
 
        Calculated Creatinine clearance  >  15 ml/min 
 
 
 
 
 
Group II: 
 
 
         Calculated Creatinine Clearance  <  15ml/min 
 
 
 
 
Each group was further divided into two sub groups depending on degree 
of proteinuria : 
 
Group I A:  
       Calculated Creatinine clearance > 15ml/min and Nephrotic range 
proteinuria (> 3.5 gm/day). 
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Group I  B: 
         Calculated  Creatinine  clearance  >  15ml/min  and  Non 
Nephrotic range proteinuria (< 3.5 gm/day). 
 
 
 
Group II A: 
         Calculated Creatinine clearance < 15ml/min and Nephrotic range 
proteinuria (> 3.5 gm/day) 
 
 
 
 
 
 
 
Group II B: 
            Calculated Creatinine clearance < 1 5 ml/min and Non Nephrotic 
range proteinuria (< 3.5 gm/day) 
 
 
 
 
 
Statistical data  was  analyzed  using  SPSS  ( Sta t is t ica l 
Package for Socia l Service) computer  program. The statistical tests 
used were 
1. Student T test 
 
 
2. Paired sample correlation test 
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RESULTS 
 
 
               This study included 68 patients, who had proteinuria 
with varying degree of  renal dysfunction, admitted in Medicine and 
Nephrology wards of Thanjavur Medical  College Hospital. The patients were 
segregated into four groups  depending on calculated creatinine clearance and 
degree of proteinuria. The results were tabulated and analyzed. 
 
Total number of patients = 68 
 
 
AGE DISTRIBUTION OF PATIENTS WITH PROTEINURIA : 
 
 
Sl.no Particulars 
No.of respondents 
(n=68) 
Percentage 
(100%) 
1 13 - 15yrs 5 7.4 
2 16 to 30yrs 26 38.2 
3 31 to 45yrs 17 25.0 
4 46 to 60yrs 14 20.6 
5 61yrs & above 6 8.8 
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AGE DISTRIBUTION OF PATIENTS WITH 
PROTEINURIA 
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In this study the age ranged from 13 to 70 years. The incidence of 
proteinuria was maximum in the age group of 16 - 30 years ( 38.2 %) . 
 
 
 
SEX DISTRIBUTION IN PATIENTS WITH PROTEINURIA 
 
 
 
Sl.no Sex 
No.of respondents 
(n=68) 
Percentage 
(100%) 
1 Male 35 51.5 
2 Female 33 48.5 
 
 
                             In this study, number of males with proteinuria was 
slightly higher than that of females. The ratio of males to females with 
proteinuria was 1.06 : 1. 
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SEX DISTRIBUTION IN PATIENTS WITH 
PROTEINURIA 
 
 
 
 
 
 
 
51% 
49% 
Sex 
Male 
Female 
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CALCULATED CREATININE CLEARANCE IN PATIENTS WITH 
PROTEINURIA 
 
Sl.no Creatinine clearance  
No.of respondents 
(n=68) 
Percentage 
(100%) 
1 < 15 ml/min 26 38.2 
2 > 15 ml/min 42 61.8 
 
 
                                In this  study,  majority  of  patients  had  > 15 ml/min  
calculated Creatinine clearance. 42 patients (61.8 %) had a Creatinine clearance 
> 15ml/min and 26 patients (38.2 %) had Creatinine clearance of < 15 
ml/min. 
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CALCULATED CREATININE CLEARANCE IN 
PATIENTS WITH PROTEINURIA 
 
 
 
 
 
 
38% 
62% 
Creatinine clearance 
< 15 ml/min 
> 15 ml/min 
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CLASSIFICATION OF PATIENTS BASED ON 
 
DEGREE PROTEINURIA 
 
Sl.no Proteinuria 
No.of respondents 
(n=68) 
Percentage 
(100%) 
1 Non nephrotic ( < 3.5 g/day ) 44 64.7 
2 Nephrotic ( > 3.5 g/day ) 24 35.3 
 
 
                                  Out of the 68 patients with p roteinuria, 24 
patients (35.3 %) had proteinuria of more than 3.5 gms/24 hours and 44 
patients (64.7%) had proteinuria less than 3.5 gms/24 hours. 
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CLASSIFICATION OF PATIENTS 
BASED ON DEGREE OF 
PROTEINURIA 
 
 
 
 
35% 
65% 
Degree of Proteinuria 
Nephrotic 
Non nephrotic 
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SEGREGATION OF PATIENTS  INTO DIFFERENT 
 
 
GROUPS 
 
The patients included in this study were segregated into 4 groups 
depending on degree of proteinuria and renal function 
 
Group I A: 
 
 
Chronic Kidney Disease other than End Stage Renal Disease i.e., 
CKD stage 1 to 4 (Calculated Creatinine clearance > 15 ml/min) with 
nephrotic range proteinuria (>3.5 gm/day) 
 
Group I B: 
 
 
Chronic Kidney Disease other than End Stage Renal Disease i.e., 
CKD stage 1 to 4 (Calculated Creatinine clearance  >  15  ml/min)  with  
non  nephrotic  range  proteinuria (<  3.5 gm/day) 
 
Group II A: 
 
 
End stage renal disease / CKD stage 5  (Calculated Creatinine 
clearance < 15ml/min) with nephrotic range proteinuria (> 3.5 gm/day) 
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Group II B : 
 
 
End stage renal disease / CKD stage 5 (Calculated Creatinine 
clearance  <  15ml/min)  with  non  nephrotic  range  proteinuria  (<  3.5 
gm/day) 
 
 
 
Calculated Creatinine 
clearance 
Nephrotic proteinuria 
Non nephrotic 
proteinuria 
> 15 ml/min 16 26 
< 15 ml/min 8 18 
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Group 
No.of respondents 
(n=68) 
Percentage 
(100%) 
I A 16 23.5 
I B 26 38.2 
II A 8 11.8 
II B 18 26.5 
 
 
 
 In this study  16 patients (23.5%) had CKD stage 1 
to 4 with nephrotic range proteinuria. There were 26 patients  (38.2 %) with 
CKD stage 1 to 4 and non nephrotic  range proteinuria.  8 patients (11.8 %) 
had ESRD / CKD stage 5 with nephrotic range proteinuria and 1 8  patients 
(26.5 %)  had ESRD / CKD stage 5 with non nephrotic range proteinuria. 
 
 
 
65 
 
 
 
SEGREGATION OF PATIENTS  INTO 
DIFFERENT GROUPS 
 
 
 
I A 
24% 
I B 
38% 
II A 
12% 
IIB 
26% 
Groups 
I A 
I B 
II A 
IIB 
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STATISTICAL ANALYSIS 
 
T-Test 
Paired Samples Statistics 
 
Correlation between Spot Urine protein creatinine ratio of the respondents 
and their Estimated 24 hours urine protein (gms) 
 
Pair 
Mea
n 
N S.D 
Correlati
on 
Sig. 
Mea
n 
S.D t 
d
f 
Sig. 
Spot 
Urine 
protein 
creatini
ne ratio 
2.575
9 
6
8 
1.269
78 
.975 
.000<0.0
5 
Significa
nt 
-
.593
5 
.3446
6 
-
14.20
1 
6
7 
.000<0.0
5 
Significa
nt 
Estimat
ed 24 
hours 
urine 
protein 
(gms) 
3.169
4 
6
8 
1.434
00 
 
Statistical test: Paired sample ‘t’ test was used the above table  
 
Inference: 
The above table indicates that there is a significant correlation between Spot 
Urine protein creatinine ratio of the respondents and their Estimated 24 hrs 
urine protein (gms). Hence the calculated value less than table value (p<0.05). 
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Correlation between Spot Urine protein creatinine ratio of Group I A and 
their Estimated 24 hours urine protein (gms) 
 
T-Test - IA 
Paired Samples Statistics 
 
Pair 
Mea
n 
N S.D 
Correlati
on 
Sig. 
Mea
n 
S.D t 
d
f 
Sig. 
Spot 
Urine 
protein 
creatini
ne ratio 
4.227
5 
1
6 
.3904
4 
.999 
.000<0.0
5 
Significa
nt 
-
.526
3 
.0158
6 
-
132.6
90 
1
5 
.000<0.0
5 
Significa
nt Estimat
ed 24 
hrs 
urine 
protein 
(gms) 
4.753
8 
1
6 
.3978
9 
 
 
Statistical test: Paired sample ‘t’ test was used for the above table  
 
Inference: 
The above table indicates that, there is a significant correlation between Spot 
Urine protein creatinine ratio of  Group I A  respondents and their Estimated 24 
hours urine protein (gms). Hence the calculated value less than table value 
(p<0.05). 
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Correlation between Spot Urine protein creatinine ratio of Group I B and 
their Estimated 24 hours urine protein (gms) 
 
T-Test - IB 
Paired Samples Statistics 
 
Pair 
Mea
n 
N S.D 
Correlati
on 
Sig. 
Mea
n 
S.D t 
d
f 
Sig. 
Spot 
Urine 
protein 
creatini
ne ratio 
1.690
8 
2
6 
.8933
4 
.999 
.000<0.0
5 
Significa
nt 
-
.266
9 
.0961
6 
-
14.15
4 
2
5 
.000<0.0
5 
Significa
nt 
Estimat
ed 24 
hrs 
urine 
protein 
(gms) 
1.957
7 
2
6 
.9799
3 
 
Statistical test: Paired sample ‘t’ test was used for the above table  
 
Inference: 
The above table indicates that there is a significant correlation between Spot 
Urine protein creatinine ratio of Group I B respondents and their Estimated 24 
hours urine protein (gms). Hence the calculated value less than table value 
(p<0.05). 
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Correlation between Spot Urine protein creatinine ratio of Group II A and 
their Estimated 24 hours urine protein (gms) 
 
T-Test – II A 
Paired Samples Statistics 
 
Pair 
Mea
n 
N S.D 
Correlat
ion 
Sig. 
Mea
n 
S.D t 
d
f 
Sig. 
Spot 
Urine 
protein 
creatin
ine 
ratio 
3.74
50 
8 
.374
13 
.868 
.005<0.
05 
Signific
ant 
-
1.25
50 
.224
75 
-
15.7
94 
7 
.000<0.
05 
Signific
ant Estima
ted 24 
hrs 
urine 
protein 
(gms) 
5.00
00 
8 
.451
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Statistical test: Paired sample ‘t’ test was used for the above table  
 
Inference: 
The above table indicates that there is a significant correlation between Spot 
Urine protein creatinine ratio of  Group II A respondents and their Estimated 24 
hours urine protein (gms). Hence the calculated value less than table value 
(p<0.05). 
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Correlation between Spot Urine protein creatinine ratio of Group II B and 
their Estimated 24 hours urine protein (gms) 
 
T-Test – II B 
Paired Samples Statistics 
 
Pair Mean N S.D 
Correl
ation 
Sig. Mean S.D t 
d
f 
Sig. 
Spot 
Urine 
protein 
creatini
ne ratio 
1.8667 18 
.217
80 
.995 
.000<
0.05 
Signi
fican
t 
-.8311 
.021
66 
-
162
.77
2 
1
7 
.000<0.
05 
Signific
ant 
Estimat
ed 24 
hrs 
urine 
protein 
(gms) 
2.6978 18 
.219
13 
 
Statistical test: Paired sample ‘t’ test was used for the above table  
 
Inference: 
The above table indicates that there is a significant correlation between Spot 
Urine protein creatinine ratio of  Group II B  respondents and their Estimated 
24 hours urine protein (gms). Hence the calculated value less than table value 
(p<0.05). 
71 
 
 
Student T-Test : Sex and inference 
 
Sex  Mean  S.D Statistical 
inference  
B. Urea (mg/dl)    
Male (n=35) 59.63 27.596 T=2.623 
.011<0.05 
Significant  Female (n=33) 43.24 23.618 
S.Creatinine (mg/dl)    
Male (n=35) 4.6771 2.53250 T=2.921 
.005<0.05 
Significant  Female (n=33) 2.9545 2.31747 
Creatinine clearance (ml/min)    
Male (n=35) 23.8809 17.01061 T=-1.800 
.077>0.05 
Not Significant  Female (n=33) 30.6709 13.83219 
Spot Urine protein creatinine 
ratio 
   
Male (n=35) 2.4946 1.24723 T=-.541 
.590>0.05 
Not Significant  Female (n=33) 2.6621 1.30697 
Estimated 24 hrs urine protein 
(gms) 
   
Male (n=35) 3.1460 1.37428 T=-.138 
.891>0.05 
Not Significant  Female (n=33) 3.1942 1.51577 
 
 
Df=66 
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Statistical test: Student‘t’ test was used the above table  
 
Inference: 
The above table denotes that there is a significant correlation between sex of the 
respondents and their B. Urea (mg/dl), S.Creatinine (mg/dl). Hence the calculate 
value less than table value (p<0.05). 
The above table signifies that there is no significant correlation between sex of 
the respondents and their Creatinine clearance (ml/min), Spot Urine protein 
creatinine ratio, Predicted 24 hrs urine protein, (gms), Estimated 24 hrs urine 
protein (gms). Hence the calculate value greater than table value (p>0.05). 
 
                                So both spot urine protein creatinine ratio and 24 hour urine 
protein tests can be performed in both sexes with accuracy. 
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Oneway ANOVA f test : Groups & Inference 
 
Outcome Mean S.D SS Df MS 
Statistical 
inference 
B. Urea 
(mg/dl) 
      
Between 
Groups 
  36514.821 3 12171.607 
F=66.082 
.000<0.05 
Significant 
I A (n=16) 30.44 7.220    
I B (n=26) 35.42 7.900    
II A (n=8) 83.50 15.856    
II B (n=18) 79.89 21.263    
Within Groups   11788.061 64 184.188 
S.Creatinine 
(mg/dl) 
      
Between 
Groups 
  359.125 3 119.708 
F=94.352 
.000<0.05 
Significant 
I A (n=16) 1.6188 .43393    
I B (n=26) 2.3077 .98343    
II A (n=8) 6.6375 1.60351    
II B (n=18) 6.7889 1.45921    
Within Groups   81.199 64 1.269 
Creatinine 
clearance 
(ml/min) 
      
Between 
Groups 
  12431.668 3 4143.889 
F=61.501 
.000<0.05 
Significant 
I A (n=16) 43.7156 10.58440    
I B (n=26) 33.4442 9.92762    
II A (n=8) 10.5038 2.51654    
II B (n=18) 10.8300 2.69573    
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Within Groups 
  
 
4312.253 
 
64 
 
67.379 
Spot Urine 
protein 
creatinine 
ratio 
      
Between 
Groups 
  84.003 3 28.001 
F=74.593 
.000<0.05 
Significant 
I A (n=16) 4.2275 .39044    
I B (n=26) 1.6908 .89334    
II A (n=8) 3.7450 .37413    
II B (n=18) 1.8667 .21780    
Within Groups   24.024 64 .375 
Estimated 24 
hrs urine 
protein (gms) 
      
Between 
Groups 
  109.149 3 36.383 
F=81.343 
.000<0.05 
Significant 
I A (n=16) 4.7538 .39789    
I B (n=26) 1.9577 .97993    
 
II A (n=8) 
 
5.0000 
 
.45170 
   
II B (n=18) 2.6978 .21913    
Within Groups   28.626 64 .447 
 
Statistical test: Oneway ANOVA‘f’ test was used the above table  
 
Inference: 
The above table denotes that there is a significant correlation among the groups 
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between  outcome of the respondents and their B. Urea (mg/dl), S.Creatinine 
(mg/dl), Creatinine clearance (ml/min), Spot Urine protein creatinine ratio, 
Predicted 24 hrs urine protein (gms), Estimated 24 hrs urine protein (gms). 
Hence the calculate value less than table value (p<0.05). 
 
 
CORRELATION CO–EFFICIENT 
 
Groups Correlation co-efficient (r) 
I A 0.999 
I B 0.999 
II A 0.868 
II B 0.995 
 
 
 
 
 
 
                         In the four groups studied, there was good 
correlation (0.975) between spot urine protein creatinine ratio and 24 
hours urine protein.  The correlation was best in patients with Creatinine 
Clearance > 15 ml/min  ( with both nephrotic and non nephrotic range  
proteinuria) (r=0.999).  The  correlation  was  least  in  patient with  End 
stage renal disease  and  nephrotic range proteinuria (r=0.868). 
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CORRELATION CO-EFFICIENT IN 
DIFFERENT GROUPS 
 
 
 
 
 
 
 
 
0.8 0.85 0.9 0.95 1 1.05 
I A 
I B 
II A 
II B 
Correlation co-efficient 
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DISCUSSION 
 
 
 
 
 
                     Measurement of urinary proteins over 24 hours is the 
definitive method to quantify proteinuria. However, continued collections 
of urine are cumbersome and often fallacious due to frequent collection 
errors 
47
. 
 
 
 
                    Sharma et al 
64  
used 3 hours urine collection to 
estimate daily urinary protein excretion in normal Indian subjects. However 
this method is unsuitable for those with severe oliguria and for the 
pediatric age group.  Apart from this, minute fallacy in the duration of 
collection period or missing a sample of urine would be exaggerated 
several folds when the values are interpreted in terms of 24 hours 
proteinuria. 
 
 
 
                    To overcome  these  difficulties,  we  estimated  24  
hour  urinary protein excretion from  single voided, spot urine sample. 
 
                 The randomly obtained urine protein Creatinine ratio can 
be expected to predict 24hour protein for several reasons 
46
. First, the 
amount of protein and Creatinine in the urine are determined by their 
excretion rates  and  by  the  tubular  reabsorption  of  water. Since  water  
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reabsorption is the same for both values of the same specimen, the protein 
– creatinine ratio therefore reflects the excretion rate of protein relative to 
creatinine. Second,  when  both urinary protein and urine creatinine values 
are reported in similar units (mg/dl), The Protein Creatinine ratio can be 
thought of as the excretion rate of urinary protein in grams relative to  the  
excretion of 1 gm creatinine. Finally, since the average person excretes 
approximately 1 gm/day creatinine, the ratio there for can be directly used 
to estimate 24 hour urinary protein in grams/day. 
 
            In this study most of the patients (98.5 %) who had 24 hour 
proteinuria > 3.5 gms had Protein Creatinine ratio  of > 3.5 gms in spot 
urine. 
 
           Vijay et al
69  
and Mohan et al 
70  
in their study found that 
prevalence of diabetes related proteinuria was 18.7% and 9.4 % 
respectively in patients with type 2 DM. In this study 19.1 % of patients 
with proteinuria were diabetics. 
 
              Ali A et al 
70
, Dilshad Ahmed Khan et al 
71
, Satish 
Basanagouda Biradar et al 
72 
and  Rathi et al 
68   
reported good 
correlation between daily urinary protein excretion rate and PCR from a 
spot urine sample. 
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                               Ginsberg et  al  
48    
also, however  pointed  out  
the  significance  of concurrent  rate  of  urinary  creatinine  excretion  in  
estimating  24hour proteinuria. 
 
                                      Ruggenenti et al
56 
in his studies concluded 
that the 24 hours urine protein  can  be  directly  predicted  from  a  
random  urine  specimen  by estimating Protein-Creatinine ratio. 
 
                               Shaw et al
71  
in assessment of proteinuria from 
protein creatinine index found good  correlation  between  protein- 
Creatinine ratio and 24  hour  urine  protein. 
 
                      In this study, the protein - Creatinine ratio of randomly 
obtained urine specimen correlated well (r = 0.975)  with 24 hours urine 
protein with varying degree of proteinuria and normal to severely 
impaired renal functions.  This is similar to the previous studies by 
Ginsberg et al (0.97), Houser et al (0.98), Schwab et al (0.98), Lemann 
and Doumas et al (0.97), Combs et al (0.98), Mitchell et al (0.98), 
Chitalia et al (0.97) and Alfredo et al (0.98) 
73
. 
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               Mohan et al 
67  
studied the correlation between the 
expected 24 hours urine protein calculated from spot urine protein –
cCreatinine ratio and the estimated 24 hours urine protein in type 2  DM. 
The positive correlation was good, but was less with increasing degree of 
proteinuria. Correlation co efficient (r) values were 0.96, 0.86, 0.74 in 
groups of  patients with proteinuria <  200 mg /day, 201 – 999 mgs/day 
and more than 1 gm/day respectively. 
 
                  Sharma et al 
64 
studied the correlation between the 
protein creatinine ratio  in spot urine sample with 24hours urine protein 
with varying degree of renal dysfunction and concluded a good positive 
correlation in patients with advanced renal failure. Correlation co  efficient 
(r) values were 0.889, 0.788, 0.375 in patients with serum creatinine < 1.5 
mg/dl, 1.5-4 mg/dl, > 4 mg/dl respectively. 
 
                        Siwach et al 
65  
found that the product of protein 
creatinine ratio and estimated daily urinary  creatinine excretion 
positively correlated well with the estimated 24 hours urine protein in 
patient with normal or mild to moderately impaired renal function ( r = 
0.88 and 0.99), but poorly correlated in patients with advanced renal failure  
( r = 0.56) 
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                           Xing G et al 
74 
found out that protein creatinine 
ratio can be used as an alternative for 24 hours urine protein estimation in 
patients with creatinine clearance > 10 ml/min. 
 
              Goldman R e t  al  
66 
found that the possible reason for 
poor correlation in these  patients  is   that  with  progression  of  renal  
failure  the  urinary Creatinine excretion falls especially after serum 
creatinine exceeds 6 mg/dl . 
 
 In this study, the best positive correlation was in patients with 
creatinine c learance > 15 ml/min (with both nephrotic and non nephrotic 
range  proteinuria) (r=0.999). The  correlation  was  least  in  patients with  
end stage renal disease  and  nephrotic range proteinuria (r=0.868). 
 
                                 Vishwanathan et al 
72
in his study showed that 
estimated proteinuria calculated from  urinary  Protein-  Creatinine  ratio  
in  a  random  urine sample is useful in  successive  evaluation of kidney 
function on a follow up basis. 
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LIMITATIONS OF THIS STUDY : 
 
 
1. Natural improvement of the study group 
2. Lab error 
3. Patient may be on drugs 
4. Small group; further large studies may be needed 
5. Correlation among spot urine samples of different timings not 
scrutinized. 
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CONCLUSION 
 
 
 
 
 
1. Protein Creatinine ratio in the spot  urine sample is found to be  an  
useful  index  for  quantification  of  proteinuria  in  patients  with varying 
degree of proteinuria and renal dysfunction. 
 
 
 
2. There  was  good  positive  correlation  between  spot  urine  Protein 
 
 
Creatinine ratio and 24 hours estimated protein. 
 
 
 
 
 
3. The correlation was best in patients with normal / mild - severely 
impaired renal dysfunction with both nephrotic and non nephrotic range 
proteinuria. The positive correlation was least in patients with end stage 
renal disease (CKD stage 5) with nephrotic range proteinuria. 
 
 
 
 4.Urine protein creatinine ratio is easy to perform, inexpensive and less 
time consuming method for measuring of proteinuria. It can thus be used in 
the out patient setting for screening and quantification of proteinuria as an 
alternative to 24 hour urine protein estimation. It can be used for follow up 
and assessment of responsiveness to therapy, by which a physician / 
Nephrologist can timely intervene so that progression of kidney disease can 
be retarded and prognosis of cardiovascular disease in diabetes mellitus can 
be improved. 
BIBLIOGRAPHY 
 
 
1. Cameron J S. The Patient with Proteinuria and/or haematuria. 
 
Oxford Textbook of Clinical Nephrology 3
rd
  edition, 2005. 
 
 
2. Denker  B,  Brenner  B.  Azotemia  and  Urinary  abnormalities. 
 
Harrison’s Principles of Internal medicine. 17th edition, 2008. 
3. Alder S G, Fairley K.  The patient with Hematuria, Proteinuria or 
both, and abnormal urinary finding on urinary microscopy. 
Manual  of  Nephrology. 7
th    
edition; 2010. 
4. Keane  W  F.  Proteinuria  :  its  clinical  importance  and  role  in 
progressive renal disease. American Journal of Kidney Disease 
2000 April, 35: S 97- S 105. 
 
 
5. Keane WF, Eknoyan G. Proteinuria, Albuminuria, Risk, 
Assessment Detection, Elimination ( PARADE): A position paper 
of  National  Kidney  foundation. American  Journal  of  Kidney 
Disease 1999; 33: 1004-1010. 
6. Carroll  MF,  Temte  JL.  proteinuria  in  adults:  A  diagnostic 
approach. American family physician 2000; 62:1333-1340. 
7. Bectham R, Cattell WR. Proteinuria :Pathophysiology, 
significance  and  recommendation for  measurement in  clinical 
practice. Ann Clin Biochem 1993; 30 : 425-434. 
8. Flanc RS, Robert MA, Strippoli GF, Chadban SJ, Kerr PG, 
Atkins RC.  Treatment of diffuse proliferative lupus nephritis: A 
meta – analysis of randomized controlled trials. Am J Kidney Dis 
2004; 43: 197-208 
 
 
9. Glassrock RJ. Postural (Orthostatic) Proteinuria N Engl J Med 
1980; 18: 395-406. 
10.Watt  GF,  Morris RW,  Khank,  Polaka Urinary  albumin 
exerction  in  health  adult  subjects. Clin Chim Acta 1988; 172: 
191-8. 
 
 
11.Spring berg PD et al. Fixed and reproducible orthostatic 
proteinuria:  Results  of  a  20  year  follow  up  study:  Annals  of 
internal medicine 1982; 97: 516-519. 
        12. Robinson  RR.  Isolated  proteinuria  in  asymptomatic  patients. 
 
 
Kidney International 1980; 18: 395-406. 
 
13.Wam LL, Yano S, Hiromurak, Tsukaday, Tomonos, Kawazer. 
 
 
Effects of  posture  on  Creatinine  clearance  and  urinary  protein 
exerction in patients with various renal diseases 1995. 
14.Devarajan P. Mechanism of orthostatic proteinuria: Lessions from a 
transplant donor. Journal of the American society of Nephrology 
1993; 4: 36-39. 
 
 
15.Shintaku N, Takahashi Y, Akaishi K, Sano A, Kuroda Y 
Entrapment of the left renal vein in children with orthostatic 
proteinuria.  Pediatric Nephrology 1990; 4:324-327. 
16.Hotter TH. Proteinuria Kidney 1987; 20:13. 
 
 
17.Kallmeyer G, Miller NM, Urinary changes in ultra-long distance 
marathon runners. Nephron 1993; 64: 119-121. 
18.Poortmans JR, Rampaer L, Walf JC. Renal Protein exerction 
after exercise in man. Eur J Apply Physiol Occup Physiol 1989; 
48: 476-480. 
 
 
19.Poortms JR, Labilloy D. The influence of work intensity on post 
exercise proteinuria. Eur J Appl Physiol Occup Physiol 1988; 
57:260-3. 
 
 
20.Abuelo JG. proteinuria : Diagnostic Principles and procedures. 
 
 
Ann Intern Med 1983:98; 186-191. 
 
21.McConnell KR, Bia MJ. The Evaluation of Proteinuria: An 
approach for the internist. Res Staff Physician 1994; 41-48. 
22.Savin VJ. Mechanism of proteinuria in non inflammatory glomerular 
disease. American Journal of Kidney Disease 1993; 21: 
347-362. 
 
 
23.Daniels BS. The role of the glomerular epithelial cell in the 
maintenance of the glomerular filtration barrier – American 
Journal of Nephrology 1993; 13: 318-323. 
24.Almeida AF. Clinical Approach to a Patient with Renal Disease  
 
      ;2003. 
  
25.Turner AN, savill J, Stewart LH, Camming A . Kidney and 
Genitourinary Disease. Davidson’s principles and practice of 
medicine. 21
st
 
 
edition 2010. 
26.Tulkensn PM, Experimental studies on Nephrotoxicity of 
 
 
Aminoglycosides in low doses. Am J Med 1986; 80 (suppl 6 B) : 
 
 
105-114. 
 
 
27.Schardijn GHC statius van eps LW. Stout – zonneveld AAM et al 
 
 
. Urinary B2- Microglobulin in urinary tract infections, Acta Clin 
 
 
Belg 1980; 35 :21. 
            28.Glassrock RJ. Proteinuria. Text book of Nephrology. 3
rd 
edition 
 
 
Baltimore : William and Wilkins, 1995. 
 
 
  29.Longo  DL,  Anderson  KC,  Plasma  Cell  Disorders Harrison’s 
       Principles of Internal medicine. 17
th 
edition, 2008. 
 
30.Beinenstock  J,  Tomasi  TB.  Secretory  gamma  –  A  in  normal 
urine. Journal of Clinical Investigation 1968; 47: 1162-1171. 
31.Rosenman E, Boss JH . Tissue antigens in normal and pathologic 
urines : A review Kidney International 1979;16: 337-344. 
32.MC Queen EG Composition of urinary casts. Lancet 1966: 397- 
 
 
398. 
 
 
33.Rustecki GJ, Goldsmith C, Sehreiner  GE characterization of 
proteins in urinary casts. Fluorescent antibody identification of 
Tanam horsfan protein in matrix and  serum protein in granules. 
New England Journal of Medicines 1971; 284: 1049-1052. 
34.Powers AC. Diabetes Mellitus Harrison’s Principles of Internal 
      medicine. 17
th 
edition, 2008. 
35.Mohan  V.  Chromic  Complication  of  Diabetes  Mellitus.  API 
     Textbook of Medicine. 7  edition; 2003. 
36.Messent JW, Elliot TG, Hill RG, Jarrett RG, Keen H, Viberti 
GC. Prognostic  Significance  of  Microalbuminuria  in  insulin 
dependent diabetes mellitus: A twenty – three year followup study. 
Kidney Int 1992; 41:836-839. 
       37. Andersons S.  Proteinuria. Primer on Kidney Disease.  2
nd  
edition 
 
 
Boston : National Kidney Foundation Academic Press ;1998. 
 
 
38.Frier BM, Fisher BM, Diabetes Mellitus Davidson’s principles and 
practice of medicine. 21
st
 
 
edition 2010. 
40.Davidson MB, Smiley JF. Relationship between dipstick positive 
proteinuria and albumin; Creatinine ratio, J Diabetes Complication 
1999; 31: 52-55. 
 
41.Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen 
 
 
CE, Pavving HH et al. Nephrology in Diabetes. Diabetes Care 
 
 
2004; 27: S 79-S 83. 
 
 
42.Meyer  NL,  Mercer  BM,  Friedman  SA  Sibai  BM.  Urinary 
dipstick protein a poor  predictor of absent or severe proteinuria. 
AM J Obstet Gynecol 1994; 170: 137-141. 
43.John WA. Chemical tests used in urinalysis.  Hutchison’s clinical 
methods. 21
st 
edition London : W.B.saunders; 2002. 
44.Bahadur MM, shah SN urinary protein in Diabetes. The Asian J 
 
 
of Diabetology 2001; 3; 14-16. 
 
 
45. Halsted CH. Malnutrition and Nutritional Assessment. 
 
Harrison’s Principles of Internal medicine. 16th edition. New Delhi 
 
 
:Mc Graw – Hill medical publishing division; 2005. 
 
 
46.Rodby RA, Rohde RD, Lewis EJ, Sharon J, Pohl MA , Bain RP 
et al. The ratio as a predictor of 24 hour urine protein exerction in 
Type I diabetic patients with Nephropathy;  American Journal of 
Kidney Disease 1995; 26: 904-909 
47.Kerr  DN.  Normal  values  in  Renal  Medicine.  Medicine  1982; 
 
 
23:1047. 
 
48.Gisberg JM, Chang BS, Matarese RA, Garella S. Use of single 
voided  urine  sample  to   estimate  quantitative  proteinuria. N 
England Journal Medicine 1983; 309: 1543-1546. 
  49.Schwab SJ, Christensen RL, Dougherty K, Klahr S. 
 
 
Quantitation of proteinuria by use of protein – to- Creatinine ratio in 
single urine samples. Arch Intern Medicine 1987; 147; 943-4. 
50.Savdan PJ, Brown MA, Farrell T, Shaw L.  Improned methods 
of assessing proteinuria in  hypertensive pregnancy. Br J Obstet 
Gynaecol 1997; 104: 1159-1164. 
51.Silink M,  Cowell CT, Rogers S. First Morning urinary albumin 
concentration  is  a  good  predictor of  24  hours urinary albumin 
exerction  in  patients  with  type  I  (insulin  dependent)  Diabetes. 
Diabetologia 1986; 29: 97-99. 
52.Koopman MG, Krediet RT, Koomen GC. Circadian Rhythm of 
proteinuria: Consequences of the use of urinary protein Creatinine 
ratio.  Nephrol Dial Transplant 1989; 4: 9-14. 
53.Wilson DM, Anderson RL. Protein - Osmolality ratio for the 
quantitative assessment of  proteinuria from a random urinalysis 
sample An J Clin Pathol 1993; 100 :419-424. 
 54. Zelmanovit Z T, Gross JL, Oliveira, De Azeredo MJ. 
 
 
Proteinuria is still useful for screening and diagnosis of oovert 
diabetic nephropathy.  Diabetes Care 1998; 21: 1076-1079. 
 55. Larson TS. Evaluation of Proteinuria. Mayo Clin Proc 1994; 
 
 
69:1154-8. 
 
 
56.Wapstra FH, Navis G, De Jong PE, De Zeeuw D. Prognostic 
value  of  the  short  –term   anti  proteinuric  response  to  ACE 
inhibition  for  predication  of  GFR  decline  in  patients  with  non 
diabetic renal disease. Exp Nephrol 1996; 4: 47-52. 
57.Maschino  G,  Alberti  D,  Janin  G,  Locatelli  F,  Mann  JFE, 
Motolese M. Effects of  the  Angiotensin Converting –enzyme 
inhibitor Benazepril on the progression of chronic renal 
insufficiency. N Eng Journal Medicine 1996; 334: 939-945. 
59.Peterson  JC,  Adler  S,  Burkart  JM,  Greene  T,  Hebert  LA, 
Hunisicker  LG  et  al. Modification of  Diet  in  Renal  Disease 
(MDRD) Study Group: Blood pressure control,  Proteinuria and 
Progression of renal disease. Ann Intern Medicine 1995; 123: 719- 
733. 
 
 
60. Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, 
Gaspari  F  Remuggi  G: Proteinuria  predicts  end  stage  renal 
failure in non diabetic chromic nephropathies.  The gruppo Italiano 
Dei study Epidemiologici in Nefrologia (GISEN) Kidney Int 1997 
63 (Suppl): S-54-S-57. 
             61. Skorecki  K,  Green  J,  Brenner  BA. Chromic Renal  
Failure. 
Harrison’s Principles of Internal medicine. 17th edition, 2008. 
62.Sharma BK, Jain PK, Jindal SK. Urinary Protein exerction in 
normal Indian subjects.  Indian Journal Med Res 1981; 74:286. 
63.Siwach  SB,  Karla  OP,  Sharma  R,  Singh  V,  Chopra  JS. 
 
 
Estimation of 24 hour protein exerction from single random urine 
specimen. Indian Journal Med Red 1990; 92; 105-108 
64.Goldman R. Creatinine exerction in renal failure. Proc soc exp 
 
 
Biol Med 1954; 85: 446. 
 
 
65.Mohan V, Viswanathan M. Estimation of 24 hours proteinuria: 
 
 
comparison of two methods. Journal Diab Ass Ind 1987; 27:73-75. 
 
 
66. Rathi  DP,  Bansal  RC,  Malhotra  K  K. Spot  urine  test  for 
quantitative  estimation of  proteinuria. J  Assoc physicians India 
1985: 33: 781-783. 
 
 
67.Vijay V, Snehalatha C, Ramachandran. A et al.  Prevalence of 
Proteinuria in non insulin dependent diabetes.  J Assoc Physicians 
India 1994: 42; 792-794. 
68.Mohan  V,  Merra  R,  Premalatha  G,  Iranda.  Frequency  of 
proteinuria  in  type  2  Diabetics seen  at  a  Diabetic  center  in 
Southern India. Post Grad Med J 2000, 76:569-573. 
69.Shaw AB,Risdon P,Lewis –Jackson JD. Protein Creatinine Index 
and Albustix in assessment of Proteinuria.Br Med J 1983;287:929. 
70. Ali A. Spot urine P/R versus 24 hours urine protein at various levels 
of GFR. J Pak Med 2008 
71. Dilshad Ahmed K. JPMA 55:428:2005 
72. Satish BB a cross sectional study JRMS 2011; 16(5): 634-639 
73. BK Yadav . Nepal Med Coll J 2010: 12(2): 100-105 
74. Xing G.  Protein to creatinine ratio in spot urine samples as a 
predictor of proteinuria Clin Chim Acta 2004 Dec ; 350(1-2) :35-9 
 
PROFORMA 
Serial No: 
Name: 
Age:    Sex:    Hospital No: 
Address: 
 
Chief complaints:      Duration 
 
Past History 
 DM 
 SHT 
 CAHD 
 Renal disease 
 Others 
 
General Examination: 
 Pallor:    Pedal edema:    
 PR:    BP: 
 Body weight: 
 
Systemic examination: 
 CVS: 
 RS: 
 P/A: 
 CNS: 
 Others: 
 Diagnosis: 
 
Investigations: 
Hb (g%):      RBS (mg/dl): 
B. Urea (mg/dl):  
S. Creatinine (mg/dl): 
S. Na (mEq/L):      S. K (mEq/L): 
Urine R/E: 
 Sugar: 
 Albumin: 
 Deposits: 
HIV:    ANA:    dsDNA: 
Others: 
USG abdomen: 
Renal Biopsy report (if already done): 
24 hours urine creatinine (mg) : 
Expected 24 hours urine creatinine (mg) : 
Adequacy of sample collection : 
 
Creatinine clearance (mL/min): 
Spot Urine Protein Creatinine ratio: 
Estimated 24 hrs urine protein (Gms): 
 
 
  
 
 
ACE 
 
 
 
 
– 
LIST OF ABBREVIATIONS USED 
 
 
Angiotensin converting enzyme 
ANA – Anti nuclear antibody 
APRI – ACE inhibitor in Progressive Renal Insufficiency 
ASO – Anti Streptolysin O 
BSA – Body surface area 
CKD – Chronic kidney disease 
DM – Diabetes mellitus 
ELISA – Enzyme linked immunosorbent assay 
ESRD – End Stage Renal Disease 
FBS – Fasting blood sugar 
FSGS – Focal segmental glomerulosclerosis 
GFR    – Glomerular filtration rate 
HBV – Hepatitis B Virus 
HCV – Hepatitis C virus 
HIV – Human Immuno deficiency virus 
HSP – Henoch Schonlein Purpura 
HT – Hypertension 
KDOQI – Kidney Disease Outcomes Quality Initiative 
MCTD – Mixed Connective Tissue Disorder 
MDRD – Modification of Diet in Renal Disease 
MPGN – Membranoproliferative glomerulonephritis 
NKF – National Kidney Foundation 
NSAIDS – Non steroidal anti inflammatory drugs 
PAN – Polyarteritis nodosa 
PSGN – Post streptococcal glomerulonephritis 
RBC – Red blood cells 
REIN – Ramipril Efficacy in Nephropathy 
RIA – Radio immune assay 
SLE – Systemic Lupus Erythematosus 
UPEP – Urine protein electrophoresis 
USG – Ultra sonogram 
UTI – Urinary tract infection 
VDRL – Venereal disease research laboratory 
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